Schmielau, Jan <br/><br/>
Combination of bortezomib, thalidomide, and dexamethasone in the treatment of relapsed, refractory IgD multiple myeloma.  [electronic resource] 

 -  Leukemia & lymphoma  Apr 2005 
 - 567-9 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.1080/10428190400029700  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Boronic Acids--administration & dosage<br/>Bortezomib<br/>Dexamethasone--administration & dosage<br/>Disease-Free Survival<br/>Fatal Outcome<br/>Humans<br/>Immunoglobulin D--blood<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--blood<br/>Pyrazines--administration & dosage<br/>Recurrence<br/>Remission Induction--methods<br/>Salvage Therapy<br/>Thalidomide--administration & dosage